A Randomized Controlled Trial Comparing the Therapeutic Efficacy and Safety of Oral Cyclosporine and Oral Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata

    May 2025 in “ Cureus
    Shibashis Chatterjee, H K Kar, Suvigya Sachan, Laxman Besra, Mitanjali Sethy
    Image of study
    TLDR Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.
    This study involving 60 patients compared the efficacy and safety of oral cyclosporine and oral betamethasone mini-pulse therapy for treating alopecia areata. Cyclosporine demonstrated a higher response rate (53.3%) compared to betamethasone (33.3%), with more patients reporting excellent or good hair regrowth. Although cyclosporine was associated with a higher incidence of mild adverse effects, such as gastrointestinal symptoms and hypertension, it was deemed superior in therapeutic efficacy, especially in severe cases. The study suggests cyclosporine as a potential first-line treatment, but recommends further large-scale studies to confirm these findings.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results